Conversely, using a 1 mL syringe is correct for 60 units, but the markings are more spread out on a 0.5 mL syringe, which offers finer precision for smaller doses
In relation to the clinical use of GLP-1R agonists for the treatment of PD, pharmacokineticpharmacodynamic correlations of each GLP-1R agonist, from relatively short acting exenatide (in the form of Byetta [twice daily] and sustained release Bydureon [once weekly]) to longer acting dulaglutide, should be closely examined as to their potency, selectivity, bloodbrain barrier (BBB) penetration, and tolerability, which may be very different from one another and ultimately impact their efficacy in PD
Get started now
If you notice changes in your sex drive while taking GLP-1 medications, you may wish to consider the following: Be open and honest, and communicate with your partner about what is going on and the changes you are experiencing so you can both understand and work together to adapt to these changes
Identification of a novel deFADding activity in human, yeast and bacterial 5 to 3 exoribonucleases
TTO analysis suggests metabolic and nutritional AEs of exenatide tend to develop later than other GLP-1 RAs
